IHS Chemical Week

Markets :: Specialty Chemicals :: Catalysts

Reaxa Secures U.K. Grant for Pharma Catalyst

9:20 AM MDT | July 21, 2010 | Laura Templer

The U.K.’s Technology Strategy Board, a U.K. government agency, has awarded £718,000 ($920,000) to a consortium led by catalyst firm Reaxa (Manchester, U.K.) to commercialize CP-STAR, a clean, low cost catalyst for processing pharmaceuticals.   CP-STAR has been developed in collaboration between Reaxa and John Blacker, professor of chemistry at the University of Leeds (Leeds, U.K.). The benefits of CP-STAR are that it can remove processing and complex purification steps in the manufacture of drugs. The catalyst can lower precious metal and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa